While this was a deviation from the original statistical plan, both the PFS and OS were significantly higher among PDL-1-positive tumours defined as PDL-1 staining ≥1% of tumour-infiltrating immune cells on immunohistochemical testing with the SP142 companion assay. The gene discussed is CD274; the disease is neoplasm.